Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease with peripheral
synovitis as its main manifestation. The presentation of the disease and the course during …

Inflammatory rheumatic diseases are generally multifaceted disorders and, therefore,
measurement of multiple outcomes is relevant to most of these diseases. Developments in …

The Outcome Measures in Rheumatoid Arthritis Clinical Trials Conference has significantly
contributed to the field of clinical outcome measurement. Agreement was achieved in …

Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA)
clinical trials, as well as to recommend specific methods for assessing each outcome …

In the past 20 years great progress has been made in the development of multidimensional
outcome measures (such as the Disease Activity Score and ACR20) to evaluate treatments …

The International League of Associations for Rheumatology (ILAR) has been meeting with
the World Health Organization (WHO) on a regular basis to discuss issues of mutual interest …

Therapies for RA are assessed in randomized clinical trials and in clinical care primarily
according to measures of inflammatory activity, which may change considerably over days …

There is no agreement as to which variable best mirrors disease activity in rheumatoid
arthritis (RA) and no studies have been performed on the validity of disease activity …

Rheumatoid arthritis (RA) clinical trials often include at least 10 measures of disease activity
(eg, tender and swollen joint counts, erythrocyte sedimentation rate, patient pain, grip …

Patient-reported outcomes in rheumatoid arthritis : Current Opinion in Rheumatology Patient-reported
outcomes in rheumatoid arthritis : Current Opinion in Rheumatology Log in or Register …